Skip to main content

#152625

Mps1 inhibitor CCT251455 Small Molecule (Tool Compound)

Cat. #152625

Mps1 inhibitor CCT251455 Small Molecule (Tool Compound)

Cat. #: 152625

Sub-type: Inhibitor

Availability: Please enquire for quantities and pricing

Application: CCT251455 displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compound to elucidate further the therapeutic potential of MPS1 inhibition. In Female Balb/C mice it had an oral bioavailabilty of 83%.

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Julian Blagg

Institute: The Institute of Cancer Research

Tool Details
Handling
Target Details
Application Details
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: Mps1 inhibitor CCT251455 Small Molecule (Tool Compound)
  • Research fields: Cancer
  • Molecular formula: C26H26ClN7O2
  • Tool sub type: Inhibitor
  • Primary target: Monopolar spindle 1 (Mps1, also known as TTK)
  • Description: The Mps1 inhibitor CCT251455 is a potent and selective chemical tool stabilizes an inactive conformation of MPS1 with the activation loop ordered in a manner incompatible with ATP and substrate-peptide binding. MPS1 is a crucial component of the spindle assembly checkpoint signal and is aberrantly overexpressed in many human cancers.
  • Application: CCT251455 displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compound to elucidate further the therapeutic potential of MPS1 inhibition. In Female Balb/C mice it had an oral bioavailabilty of 83%.
  • Purpose: Inhibitor
  • Additional notes: Published poster at the 2012 AACR meeting: http://cancerres.aacrjournals.org/content/72/8_Supplement/1817.short

Handling

  • Purity: 503.99 g/mol
  • Shipping conditions: Dry Ice

Target Details

  • Primary target: Monopolar spindle 1 (Mps1, also known as TTK)
  • Ic50: IC50 of 0.003uM in MPS1 assay, p-MPS1 Cell Assay IC50 of 0.04uM and a GI50 of 0.16uM in HT-116 Human Colon Cancer cell line.

Application Details

  • Application: CCT251455 displays a favorable oral pharmacokinetic profile, shows dose-dependent inhibition of MPS1 in an HCT116 human tumor xenograft model, and is an attractive tool compound to elucidate further the therapeutic potential of MPS1 inhibition. In Female Balb/C mice it had an oral bioavailabilty of 83%.

References

  • J. Med. Chem. 2013, 56, 10045-10065. PMID: 24256217

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.